• Profile
Close

Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: A post hoc analysis of a double-blind, randomized clinical trial

Nephrology Dialysis Transplantation Oct 08, 2018

Spoto B, et al. - Researchers examined chronic kidney disease (CKD) patients to analyze static (baseline adiponectin levels) and dynamic (fluctuations in adiponectin levels) interactions of serum adiponectin with the FGF23 response to paricalcitol and placebo. They found that FGF23 response to VDR activation in CKD patients was strongly altered by adiponectin. Paricalcitol- vs placebo-induced VDR activation noticeably increased serum FGF23 levels, and patients in the 4th adiponectin quartile showed an even larger increase vs other quartiles, while no such effect was seen in the placebo group. In the FGF23 response to VDR activation in CKD patients, mechanistic relevance of the adiponectin–FGF23 link (discovered in genetically engineered mice) was suggested.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay